Total Payments
$6,173
2024 Payments
$2,492
Companies
31
Transactions
303
Medicare Patients
2,510
Medicare Billing
$248,044
Payment Breakdown by Category
Food & Beverage$6,173 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,173 | 303 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,262 | 68 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,203 | 50 | $0 (2024) |
| GlaxoSmithKline, LLC. | $943.14 | 49 | $0 (2024) |
| ABBVIE INC. | $556.13 | 21 | $0 (2024) |
| Lilly USA, LLC | $338.69 | 20 | $0 (2024) |
| Antares Pharma, Inc. | $318.04 | 18 | $0 (2024) |
| Astellas Pharma US Inc | $217.15 | 5 | $0 (2024) |
| PFIZER INC. | $206.40 | 13 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $186.66 | 10 | $0 (2024) |
| Dexcom, Inc. | $133.53 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,492 | 102 | AstraZeneca Pharmaceuticals LP ($588.59) |
| 2023 | $986.35 | 45 | AbbVie Inc. ($266.57) |
| 2022 | $892.32 | 50 | Novo Nordisk Inc ($274.71) |
| 2021 | $351.35 | 20 | Novo Nordisk Inc ($120.93) |
| 2020 | $71.15 | 5 | PFIZER INC. ($39.00) |
| 2019 | $667.96 | 38 | GlaxoSmithKline, LLC. ($192.87) |
| 2018 | $430.55 | 22 | GlaxoSmithKline, LLC. ($272.61) |
| 2017 | $281.24 | 21 | GlaxoSmithKline, LLC. ($109.01) |
All Payment Transactions
303 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: Diabetes | ||||||
| 12/26/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: Diabetes | ||||||
| 12/16/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $25.08 | General |
| Category: Diabetes | ||||||
| 12/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $27.50 | General |
| Category: Diabetes | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/02/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.66 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $24.49 | General |
| 11/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: DIABETES | ||||||
| 11/05/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $6.11 | General |
| Category: Obesity | ||||||
| 11/04/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: Oncology | ||||||
| 10/21/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/15/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: Diabetes | ||||||
| 10/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Obesity | ||||||
| 10/09/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: Biological | ||||||
| 10/08/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: Respiratory | ||||||
| 10/07/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: VACCINES | ||||||
| 10/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.39 | General |
| 09/25/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $115.75 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/18/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Obesity | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $68.06 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 551 | 725 | $198,440 | $63,568 |
| 2022 | 12 | 625 | 960 | $173,244 | $62,840 |
| 2021 | 11 | 637 | 902 | $140,622 | $62,497 |
| 2020 | 13 | 697 | 933 | $151,203 | $59,139 |
Total Patients
2,510
Total Services
3,520
Medicare Billing
$248,044
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 194 | 358 | $101,404 | $28,694 | 28.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 135 | 135 | $52,785 | $17,609 | 33.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 25 | 25 | $11,350 | $7,024 | 61.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 94 | 96 | $19,133 | $5,066 | 26.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 18 | 18 | $9,000 | $3,003 | 33.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 11 | 11 | $1,375 | $791.23 | 57.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 25 | 25 | $1,325 | $763.00 | 57.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 11 | 11 | $660.00 | $335.72 | 50.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 17 | 18 | $1,044 | $187.04 | 17.9% |
| 81002 | Urinalysis, manual test | Office | 2023 | 21 | 28 | $364.00 | $95.48 | 26.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 206 | 396 | $90,420 | $30,175 | 33.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 155 | 155 | $48,056 | $20,460 | 42.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 95 | 98 | $15,481 | $4,478 | 28.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 14 | 14 | $5,500 | $2,374 | 43.2% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 12 | 12 | $3,138 | $2,034 | 64.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 21 | 21 | $3,148 | $1,436 | 45.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 22 | 22 | $1,285 | $647.40 | 50.4% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 15 | 18 | $2,310 | $548.86 | 23.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 26 | 42 | $2,484 | $465.17 | 18.7% |
| 81002 | Urinalysis, manual test | Office | 2022 | 25 | 34 | $358.00 | $116.87 | 32.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 11 | 12 | $656.00 | $92.29 | 14.1% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 23 | 136 | $408.00 | $12.09 | 3.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 220 | 364 | $78,260 | $30,456 | 38.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 159 | 159 | $39,750 | $21,494 | 54.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 59 | 71 | $10,437 | $4,149 | 39.8% |
About Dr. Attri Datta, M.D
Dr. Attri Datta, M.D is a Family Medicine healthcare provider based in Woodstock, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2011. The National Provider Identifier (NPI) number assigned to this provider is 1730471236.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Attri Datta, M.D has received a total of $6,173 in payments from pharmaceutical and medical device companies, with $2,492 received in 2024. These payments were reported across 303 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($6,173).
As a Medicare-enrolled provider, Datta has provided services to 2,510 Medicare beneficiaries, totaling 3,520 services with total Medicare billing of $248,044. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Woodstock, GA
- Active Since 05/03/2011
- Last Updated 11/05/2019
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1730471236
Products in Payments
- FARXIGA (Drug) $588.47
- VRAYLAR (Drug) $544.50
- Ozempic (Drug) $510.66
- TRELEGY ELLIPTA (Drug) $482.33
- AIRSUPRA (Drug) $435.62
- Rybelsus (Drug) $232.49
- JARDIANCE (Drug) $221.77
- Veozah (Drug) $217.15
- MOUNJARO (Drug) $177.82
- ANORO (Drug) $159.57
- AREXVY (Drug) $150.48
- NOCDURNA (Drug) $145.47
- BREZTRI (Drug) $137.94
- Dexcom G6 Transmitter (Medical Supply) $133.53
- Cologuard Collection Kit (Device) $130.99
- XYOSTED (Drug) $122.03
- NURTEC ODT (Drug) $115.42
- Victoza (Drug) $109.36
- CHANTIX (Drug) $102.56
- ADVAIR (Drug) $83.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Woodstock
Dr. James Lee, D.o, D.O
Family Medicine — Payments: $12,939
Family Medicine $12,939
Dr. Kirk-Conrod Hewling, Md, MD
Family Medicine — Payments: $10,035
Family Medicine $10,035
Dr. Scott Macleod, Md, MD
Family Medicine — Payments: $9,141
Family Medicine $9,141
Dr. Lata Parvathaneni, Md, MD
Family Medicine — Payments: $7,525
Family Medicine $7,525
Baby Than, Md, MD
Family Medicine — Payments: $7,317
Family Medicine $7,317
Dr. Robert Hudec, Md, MD
Family Medicine — Payments: $7,139
Family Medicine $7,139